GlassScriptPhysician profile
Parth Makker
NPI 1164797551
$40,101.83
in general payments reported to CMS, 2019-2025
39 companies · $4,973 in 2025
The $4,973 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,538 · 2020: $8,730 · 2021: $2,311 · 2022: $4,205 · 2023: $7,376 · 2024: $3,968 · 2025: $4,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,675 · Food and Beverage: $6,948 · Travel and Lodging: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,675.00 |
| Food and Beverage | $6,948.42 |
| Travel and Lodging | $1,693.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,015.05 | 2019-2025 | Ensite, Advisor, Ensite Precision |
| Boston Scientific Corporation | $7,602.60 | 2019-2025 | Eluvia, Watchman Access System, Varithena Administration Pack |
| Medtronic Vascular, INC. | $5,088.14 | 2019-2020 | |
| Medtronic, INC. | $3,178.63 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $1,027.57 | 2019-2025 | Biomonitor |
| Biosense Webster, INC. | $1,025.13 | 2022-2025 | Carto 3, Octaray Mapping Catheter |
| E.R. Squibb & Sons, L.L.C. | $448.15 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $382.94 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $347.41 | 2019-2024 | Xarelto |
| Amgen INC. | $292.07 | 2019-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $283.62 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $244.39 | 2019-2025 | |
| Heartflow, INC. | $234.32 | 2022-2025 | |
| Abiomed | $233.02 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $204.09 | 2022-2025 | Amvuttra, Onpattro |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Makker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.